Former FDA head takes place on Pfizer board

Pfizer has appointed former US Food and Drug Administration (FDA) commissioner Scott Gottlieb to its board.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

FDA chief Gottlieb resigns after nearly two years

6 March 2019 Scott Gottlieb, commissioner of the US Food and Drug Administration, resigned from his post yesterday, March 5, with plans to step down in the next month.

Americas

National Cancer Institute’s director named as acting FDA chief

13 March 2019 The Trump administration has named Ned Sharpless, director of the National Cancer Institute, as the Food and Drug Administration's (FDA) acting commissioner.

Big Pharma

Pfizer off-patent division to merge with Mylan

29 July 2019 Pfizer is to merge its off-patent drug business Upjohn with Mylan, in a deal that will see Pfizer shareholders own 57% of the new company.

More on this story

Americas

FDA chief Gottlieb resigns after nearly two years

6 March 2019 Scott Gottlieb, commissioner of the US Food and Drug Administration, resigned from his post yesterday, March 5, with plans to step down in the next month.

Americas

National Cancer Institute’s director named as acting FDA chief

13 March 2019 The Trump administration has named Ned Sharpless, director of the National Cancer Institute, as the Food and Drug Administration's (FDA) acting commissioner.

Big Pharma

Pfizer off-patent division to merge with Mylan

29 July 2019 Pfizer is to merge its off-patent drug business Upjohn with Mylan, in a deal that will see Pfizer shareholders own 57% of the new company.

More on this story

Americas

FDA chief Gottlieb resigns after nearly two years

6 March 2019 Scott Gottlieb, commissioner of the US Food and Drug Administration, resigned from his post yesterday, March 5, with plans to step down in the next month.

Americas

National Cancer Institute’s director named as acting FDA chief

13 March 2019 The Trump administration has named Ned Sharpless, director of the National Cancer Institute, as the Food and Drug Administration's (FDA) acting commissioner.

Big Pharma

Pfizer off-patent division to merge with Mylan

29 July 2019 Pfizer is to merge its off-patent drug business Upjohn with Mylan, in a deal that will see Pfizer shareholders own 57% of the new company.

More features

Fed Circ orders Teva to delist five patents from Orange Book

Sarepta wins $115M in patent dispute over muscular dystrophy drug

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York

Former FDA head takes place on Pfizer board

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features